Paper21132010
GNL3L depletion destabilizes MDM2 and induces p53-dependent G2/M arrest.
Meng L and 2 others. Oncogene, 2011. Cited by 37 papers, by iCite.
Cite this record
ConductScience Library. GNL3L depletion destabilizes MDM2 and induces p53-dependent G2/M arrest. Papers, record 21132010. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/21132010
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cell Cycle | Major topic |
| GTP-Binding Proteins | Major topic |
| Nuclear Proteins | Major topic |
| Proto-Oncogene Proteins c-mdm2 | Major topic |
| Tumor Suppressor Protein p53 | Major topic |
| 14-3-3 Proteins | |
| Biomarkers, Tumor | |
| Carcinoma | |
| Cell Division | |
| Cyclin-Dependent Kinase Inhibitor p21 | |
| Exonucleases | |
| Exoribonucleases | |
| G2 Phase | |
| Gastrointestinal Neoplasms | |
| HCT116 Cells | |
| Humans | |
| Ubiquitination | |
| Up-Regulation | |
| bcl-2-Associated X Protein |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| R01 CA113750 | NCI NIH HHS | United States | R01CA113750 | PubMed and NIH |
Source NIH RePORTER
References30
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 16857591 | Dual-site regulation of MDM2 E3-ubiquitin ligase activity. | Mol Cell | 2006 | https://conductscience.org/library/papers/16857591 | PubMed |
| 2 | 18426907 | Aberrant expression of nucleostemin activates p53 and induces cell cycle arrest via inhibition of MDM2. | Mol Cell Biol | 2008 | https://conductscience.org/library/papers/18426907 | PubMed |
| 3 | 17158916 | Multiple controls regulate nucleostemin partitioning between nucleolus and nucleoplasm. | J Cell Sci | 2006 | https://conductscience.org/library/papers/17158916 | PubMed |
| 4 | 15314174 | Inhibition of HDM2 and activation of p53 by ribosomal protein L23. | Mol Cell Biol | 2004 | https://conductscience.org/library/papers/15314174 | PubMed |
| 5 | 9822382 | Requirement for p53 and p21 to sustain G2 arrest after DNA damage. | Science | 1998 | https://conductscience.org/library/papers/9822382 | PubMed |
| 6 | 19706044 | Differential effects of Nucleostemin suppression on cell cycle arrest and apoptosis in the bladder cancer cell lines 5637 and SW1710. | Cell Prolif | 2009 | https://conductscience.org/library/papers/19706044 | PubMed |
| 7 | 17923687 | Nucleolar trafficking of nucleostemin family proteins: common versus protein-specific mechanisms. | Mol Cell Biol | 2007 | https://conductscience.org/library/papers/17923687 | PubMed |
| 8 | 14612427 | Ribosomal protein L11 negatively regulates oncoprotein MDM2 and mediates a p53-dependent ribosomal-stress checkpoint pathway. | Mol Cell Biol | 2003 | https://conductscience.org/library/papers/14612427 | PubMed |
| 9 | 9659898 | 14-3-3sigma is a p53-regulated inhibitor of G2/M progression. | Mol Cell | 1997 | https://conductscience.org/library/papers/9659898 | PubMed |
| 10 | 17000763 | Nucleostemin delays cellular senescence and negatively regulates TRF1 protein stability. | Mol Cell Biol | 2006 | https://conductscience.org/library/papers/17000763 | PubMed |
| 11 | 12898521 | Characterization of mesenchymal stem cells isolated from murine bone marrow by negative selection. | J Cell Biochem | 2003 | https://conductscience.org/library/papers/12898521 | PubMed |
| 12 | 18802033 | Identification of stem cells during prepubertal spermatogenesis via monitoring of nucleostemin promoter activity. | Stem Cells | 2008 | https://conductscience.org/library/papers/18802033 | PubMed |
| 13 | 10722742 | Mdm2 is a RING finger-dependent ubiquitin protein ligase for itself and p53. | J Biol Chem | 2000 | https://conductscience.org/library/papers/10722742 | PubMed |
| 14 | 19318567 | Depletion of guanine nucleotides leads to the Mdm2-dependent proteasomal degradation of nucleostemin. | Cancer Res | 2009 | https://conductscience.org/library/papers/19318567 | PubMed |
| 15 | 19487455 | GNL3L stabilizes the TRF1 complex and promotes mitotic transition. | J Cell Biol | 2009 | https://conductscience.org/library/papers/19487455 | PubMed |
| 16 | 19501670 | Nucleostemin: a latecomer with new tricks. | Int J Biochem Cell Biol | 2009 | https://conductscience.org/library/papers/19501670 | PubMed |
| 17 | 19033382 | Nucleoplasmic mobilization of nucleostemin stabilizes MDM2 and promotes G2-M progression and cell survival. | J Cell Sci | 2008 | https://conductscience.org/library/papers/19033382 | PubMed |
| 18 | 17623774 | GNL3L inhibits activity of estrogen-related receptor gamma by competing for coactivator binding. | J Cell Sci | 2007 | https://conductscience.org/library/papers/17623774 | PubMed |
| 19 | 10074902 | Analysis of the degradation function of Mdm2. | Cell Growth Differ | 1999 | https://conductscience.org/library/papers/10074902 | PubMed |
| 20 | 15144954 | Nucleolar protein NPM interacts with HDM2 and protects tumor suppressor protein p53 from HDM2-mediated degradation. | Cancer Cell | 2004 | https://conductscience.org/library/papers/15144954 | PubMed |
Cited by27
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 37 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42444932 | GNL3L-LMNB1 signaling axis promotes lung squamous cell carcinoma growth and ferroptosis resistance via NF-κB activation. | J Thorac Dis | 2026 | https://conductscience.org/library/papers/42444932 | PubMed |
| 40856423 | The GNL3L-MDM2 Interaction Drives Esophageal Squamous Cell Carcinoma Progression. | Cancer Med | 2025 | https://conductscience.org/library/papers/40856423 | PubMed |
| 39519555 | DNA Methylation Signatures Characterize Gene Expression Modulation in Lung Cancer Patients Affected by Anorexia. | Nutrients | 2024 | https://conductscience.org/library/papers/39519555 | PubMed |
| 39285385 | The Abl1 tyrosine kinase is a key player in doxorubicin-induced cardiomyopathy and its p53/p73 cell death mediated signaling differs in atrial and ventricular cardiomyocytes. | J Transl Med | 2024 | https://conductscience.org/library/papers/39285385 | PubMed |
| 39259742 | Transcriptional control of a stem cell factor nucleostemin in liver regeneration and aging. | PLoS One | 2024 | https://conductscience.org/library/papers/39259742 | PubMed |
| 38947394 | GNL3L exhibits pro-tumor activities via NF-κB pathway as a poor prognostic factor in acute myeloid leukemia. | J Cancer | 2024 | https://conductscience.org/library/papers/38947394 | PubMed |
| 38148364 | GNL3L promotes autophagy via regulating AMPK signaling in esophageal cancer cells. | Med Oncol | 2023 | https://conductscience.org/library/papers/38148364 | PubMed |
| 37548770 | Characterization of stem cell subtypes and prognostic signature in hepatocellular carcinoma. | J Cancer Res Clin Oncol | 2023 | https://conductscience.org/library/papers/37548770 | PubMed |
| 36230520 | Multi-Omics Analysis of GNL3L Expression, Prognosis, and Immune Value in Pan-Cancer. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/36230520 | PubMed |
| 36069077 | GNL3 is an evolutionarily conserved stem cell gene influencing cell proliferation, animal growth and regeneration in the hydrozoan Hydractinia. | Open Biol | 2022 | https://conductscience.org/library/papers/36069077 | PubMed |
| 33300035 | MiR-CLIP reveals iso-miR selective regulation in the miR-124 targetome. | Nucleic Acids Res | 2021 | https://conductscience.org/library/papers/33300035 | PubMed |
| 33147101 | Guanine nucleotide binding protein like-1 (GNL1) promotes cancer cell proliferation and survival through AKT/p21 CIP1 signaling cascade. | Mol Biol Cell | 2020 | https://conductscience.org/library/papers/33147101 | PubMed |
| 32422901 | Chemoresistance-Associated Silencing of miR-4454 Promotes Colorectal Cancer Aggression through the GNL3L and NF-κB Pathway. | Cancers (Basel) | 2020 | https://conductscience.org/library/papers/32422901 | PubMed |
| 31562322 | 12 new susceptibility loci for prostate cancer identified by genome-wide association study in Japanese population. | Nat Commun | 2019 | https://conductscience.org/library/papers/31562322 | PubMed |
| 30061673 | Interplay between human nucleolar GNL1 and RPS20 is critical to modulate cell proliferation. | Sci Rep | 2018 | https://conductscience.org/library/papers/30061673 | PubMed |
| 28039451 | High-throughput proteome analysis reveals targeted TRPM8 degradation in prostate cancer. | Oncotarget | 2017 | https://conductscience.org/library/papers/28039451 | PubMed |
| 27764577 | Leucine Zipper Down-regulated in Cancer-1 (LDOC1) interacts with Guanine nucleotide binding protein-like 3-like (GNL3L) to modulate Nuclear Factor-kappa B (NF-κB) signaling during cell proliferation. | Cell Cycle | 2016 | https://conductscience.org/library/papers/27764577 | PubMed |
| 26835157 | p53 Configures the G2/M Arrest Response of Nucleostemin-Deficient Cells. | Cell Death Discov | 2015 | https://conductscience.org/library/papers/26835157 | PubMed |
| 26274615 | GNL3L Is a Nucleo-Cytoplasmic Shuttling Protein: Role in Cell Cycle Regulation. | PLoS One | 2015 | https://conductscience.org/library/papers/26274615 | PubMed |
| 26203195 | Nucleolar GTP-binding Protein-1 (NGP-1) Promotes G1 to S Phase Transition by Activating Cyclin-dependent Kinase Inhibitor p21 Cip1/Waf1. | J Biol Chem | 2015 | https://conductscience.org/library/papers/26203195 | PubMed |
Genes30
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/21132010
GET https://conductscience.org/api/papers/v1/21132010/references?page=2